Follow live market commentary on Facebook. Click here
Close
Sify News
www
Get Quote
NAVs
News
Follow us on
 
SENSEX
 
 
STOCKS LAST SEARCHED
   
IMAGEGALLERY
   
GOLD RATE
Rs. 29135.00
(10 gm)
Glitter Estimator
   
Get Company Quotes
Hot search: SBI, RIL, L&T, Infosys, ICICI Bank
Quote in alphabetical order:
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
 
 
Sify Home » Finance » Equity » Overview

D S Q Biotech Ltd. Share Price

BSE : 17020028 | NSE : SQUAREDBIOBE | ISIN : INE964A01019   Compare with Peers   Go
Overview Financial Competitors Editors Pick  
 
 
  BSE     3.80 0.00 NSE     13.40 0.00
Your Take on D S Q Biotech Ltd. | Graph  
 
 
Current 3.80 Vol 144618
High 0.00 52 WK 7.59
Low 0.00 52 WK 2.37
Prev. Close 3.80 Change% 0
 
 
 
Current 13.40 Vol 91652
High 0.00 52 WK 0.00
Low 0.00 52 WK 0.00
Prev. Close 13.40 Change% 0
 
   
 
 
 
  •  
    In Focus Latest News Photos Videos
     
     
    BSE
    Feb 12 2003 12:00AM
    P/E Ratio N/A EPS N/A
    Volume 144618 Face Value 10.00
    NSE
    May 07 2002 12:00AM
    P/E Ratio N/A EPS N/A
    Volume 91652 Face Value 10.00
    Historic Quotes of D S Q Biotech Ltd.
    Start Date
    End Date
    BSE NSE Graph
    Frequency
     
    Share Holdings of D S Q Biotech Ltd.
      Scheme No. of Shares  
    More Fund Action in D S Q Biotech Ltd.
    Financials of D S Q Biotech Ltd.
         
     
  •    
     
  •  
      Company Name Current Price   Prev Price   High Price   Low Price  
      D S Q Biotech Ltd. 3.8   3.8   0   0  
      Kaveri Seed Company Ltd. 706.30   721.65   720.00   704.30  
      Advanta India Ltd. 471.80   457.35   477.40   457.50  
      J K Agri Genetics Ltd. 287.00   287.00   301.95   281.05  
      Omega Ag-Seeds (Punjab) Ltd. 19.00   18.40   19.05   17.65  
      Titan Bio-Tech Ltd. 13.09   13.09   13.09   13.09  
     
       
     
  •  
    Live Market Voice- BSE Sensex
     
       
    •  Indian Oil sees 2012/13 capex at $1.8 bln-exec
    •  European shares boosted by Greece, risks not over
    •  Ranbaxy gets U.S. OK for acne treatment
    •  Reliance Comm tower talks await rule clarity
      More
     
    Images
     
     
    Videos
     
     
     
 
 
Information
•  Profile
•  History
•  Location
•  Capital Structure
•  Share Holdings
•  Historic Prices
   
 
•  Board of Directors
•  Key Executives
•  Products
•  Year High Lows
•  Announcements
 
Financials
•  Profit and Loss
•  Balance Sheet
•  Ratios
•  Cash Flows
•  Quarterly Results
•  Half Yearly Result
•  Nine Months
•  Yearly Result
 
Other Info
•  Auditors
•  Board Meetings
•  GDR
•  Closing Prices
•  52 Week High Lows
   
 
•  Bankers
•  FII Activity
•  ADR
•  Monthly High Lows
•  Indices
 
 
Info
 
•  Profile
•  Share Holdings
•  Historic Prices
•  52 Week Highlow